期刊文献+

四种不同膜材料透析器生物相容性的临床研究 被引量:3

Clinical study on biocompatibility of four dialyzers with different membranes
原文传递
导出
摘要 目的观察4种不同膜材料透析器临床应用过程中的生物相容性。方法60例维持性血液透析(MHD)患者入选,进行前瞻、随机、对照、队列研究。在基线水平所有患者均应用聚砜(PS)膜透析器透析至少3个月,随后患者按随机数字法分配入3个不同膜材质透析器组:聚醚砜膜(PES)组、三醋酸纤维素膜(CTA)组和聚甲基丙烯酸甲酯膜(PMMA)组,观察6个月。透析器无复用,在不同的时间点测定生物相容性指标进行比较:结果血超敏C反应蛋白(hsCRP)、白细胞介素(IL)1B、IL-13、红细胞计数、血小板计数在不同组之间及分组前(0)、3、6个月透析前后进行比较,差异均无统计学意义。透析过程中,血补体C3a、C5a水平均先升后降。PMMA组在0个月时透析0min、15min、240min补体C3a为(117.92±35.99)、(183.09±57.02)、(135.20±43.08)μg/L;在3个月时分别为(96.11±30.84)、(141.48±50.70)、(115.38±37.49)μg/L;在6个月时分别为(85.05±17.28)、(146.31±41.07)、(116.69±32.95)Ixg/L,0个月分别与3个月、6个月间C3a水平差异有统计学意义(均P〈0.05)。3个月时PMMA组透析0min、15min、240minC5a为(60.59±19.07)、(85.30±23.50)、(72.74±28.97)μg/L,PES组透析0min、15min、240minC5a为(74.70±18.70)、(98.85±27.78)、(83.96±27.87)μg/L,两组间差异有统计学意义(P〈0.05)。白细胞计数(WBC,×10^9/L)在透析过程中先降后升。PMMA组WBC0个月、3个月、6个月的透析0min为(5.60±1.42)、(6.02±1.36)、(6.45±1.29)(均P〈0.05);15min为(4.44±0.98)、(2.32±1.11)、(2.20±1.42)(均P〈0.01):0个月、6个月的透析30min为(5.64±1.22)、(4.74±1.35)(P=0.026);60min为(5.97±0.82)、(6.82±1.58)(P=0.39);240min为(7.41±1.87)、(8.44±1.61)(P=0.001);3个月、6个月的透析240min为(7.53±2.31)、(8.44±1.61)(P=0.004)。差异均有统计学意义。结论4种膜材料透析器生物相容性存在一定的差异。 Objective To elucidate the bioeompatibility differences of 4 dialyzers with different membranes in maintenance hemodialysis (MHD) patients. Methods A total of 60 MHD patients were enrolled in the prospective, randomized, control, cohort study. In baseline, synthetic polysulfone (PS) membrane dialyzer was used in all the patients for at least 3 months. Then the patients were randomly divided into three groups: ployethersulfone (PES) membrane group, cellulose triacetate (CTA) membrane group, and synthetic polymethyhnethaerylate (PMMA) membrane group. Study duration was 6 months. No dialyzer was reused. The bioeompatibility markers were detected repeatedly at different time points and compared with each other in different dialyzer groups. Results The blood levels of high sensitive C reactive protein, interleukin-1β, and interleukin-13 were not significantly different among different groups on every time point. However, the blood complements levels and WBC count were significantly different among four kinds of dialyzer. When the dialyzers changed from PS to PMMA membrane, C3a levels and WBC count changed significantly (P〈0.05). Moreover, the change of CSa level was significantly different between PES group and PMMA group on month 3 (P〈0.05). Conclusion There are some differences of biocompatibiliy among different dialyzer membranes.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2011年第4期253-258,共6页 Chinese Journal of Nephrology
基金 北京市科学技术委员会专项课题基金(D09050704310903) 首都医科大学基础与临床合作科研课题(10JL26)
关键词 血液透析 透析器 生物相容性 Hemodialysis Dialyzer Biocompatibility
  • 相关文献

参考文献25

  • 1MacLeod A,Daly C,Khan I,et al.Comparison of cellulose,modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.Cochrane Database Syst Rev,2001,3:CD003234.
  • 2Angela K,G(o)t Z,Carsten A,et al.Effect of membrane flux and dialyzer biocompatibility on survival in end-stage diabetic nephropathy.Nephron Clin Pract,2008,109:c154-c160.
  • 3Bergstrom J,Wehle B.No change in corrected beta2microglobulin concentration after cuprophane haemodialysis.Lancet,1987,1:628-629.
  • 4Varela MP,Kimmel PL,Phillips TM,et al.Biocompatibility of hemodialysis membranes:interrelations between plasma complement and cytokine levels.Blood Purif,2001,19:370-379.
  • 5Grooteman MPC,Nubé MJ.Impact of the type of dialyser on the clinical outcome in chronic haemodialysis patients:does it really matter?Nephrol Dial Transplant,2004,19:2965-2970.
  • 6Clark WR,Macias WL,Molitos BA,et al.Plasma protein adsorption to highly permeable hemodialysis membranes.Kidney Int,1995,48:481-488.
  • 7Goldman M,Lagniehe M,Dhaene M,et al.Adsorption of beta2-microglobulin on dialysis membranes:comparison of different dialyzers and effects of reuse procedures.Int J Artif Organs,1989,12:373-378.
  • 8Klinke B,Rockel A,Abdelhamid S,et al.Transmembranous transport of beta2-microglobulin during hemodialysis using polysulfone,polyacrylonitrile,polymethylmethacrylate and cupra mmomium rayon membranes.Int J Artif Organs,1989,12:697-702.
  • 9Aoike I.Clinical significance of protein adsorbable membranes-long-term clinical effects and analysis using a proteomic technique.Nephrol Dial Transplant,2007,22Suppl 5:v13-v19.
  • 10Yamashita AC,Tomisawa N.Importance of membrane materials for blood purification devices in critical care.Transfus Apher Sci,2009,40:23-31.

二级参考文献18

  • 1王质刚.透析膜生物相容性与临床关系[J].肾脏病与透析肾移植杂志,1995,4(2):182-187. 被引量:7
  • 2Macleod AM, Campbell M, Cody JD. Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease[J]. Cochrane Database Syst Rev, 2005, 20:3234-3239.
  • 3Chanard J, Lavaud S, Randoux C, et al. New insights in dialysis membrane biocompatibility: Relevance of adsorption properties and heparin binding[J]. Nephrol Dial Transpl, 2003, 18: 252-257.
  • 4Chanard J. Membrane biocompatibility in dialysis: the role of absorption[J]. Nephrologie, 2003, 24:359-365.
  • 5Stefen H, Jurgen B. Apoptosis cultured from long term hemodialysis patients[J]. Kidney Int, 2004, 89:792-799.
  • 6Klinkmann H. The biocompatibility puzzle-Partly solved, partly enigmatic[J]. Nephrol Dial Transpl, 1998, 9:184-186.
  • 7Cohen J, Dukie RC. Apoptosis and programmed cell death in immunity[J]. Annu Rev Immunol, 1992, 10: 267-293.
  • 8Carracedo J, Rafaul R. Cell aggregation and apoptosis induced by hemodialysis membrane[J]. Kidney Int, 2002, 45: 89-93.
  • 9Mangan DE, Robertson B. IL-4 enhanced apoptosis in stimulated human monocytes[J]. J Immunol, 1991, 148:1812- 1816.
  • 10Von-Appen-K, Mell P. Leukocyte adhesion molecules as biocompatibility marker for hemodialysis membranes[J]. ASAIO-J, 1994,40: 609-615.

共引文献13

同被引文献52

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部